| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |